Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature.
第一作者:
Eva,Vermeer
第一单位:
Department of Paediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. e.vermeer@amsterdamumc.nl.;Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam UMC, Amsterdam, the Netherlands. e.vermeer@amsterdamumc.nl.;Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, Amsterdam, the Netherlands. e.vermeer@amsterdamumc.nl.
作者:
医学主题词
人类(Humans);甲氨蝶呤(Methotrexate);抗风湿药(Antirheumatic Agents);注射, 皮下(Injections, Subcutaneous);投药, 口服(Administration, Oral)
DOI
10.1007/s11926-023-01116-7
PMID
37768405
发布时间
2024-06-05
- 浏览0
Current rheumatology reports
276-284页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



